GOETTINGEN, Germany--(BUSINESS WIRE)--Sartorius (FWB:SRT), a leading international pharmaceutical and laboratory equipment supplier, grew dynamically in both divisions in fiscal 2016 according to its preliminary figures and achieved its financial targets raised at mid-year.
"The year 2016 was highly successful for Sartorius, both operationally and strategically," commented CEO Dr. Joachim Kreuzburg. "Our Bioprocess Solutions Division is continuing to expand strongly.
"The year 2016 was highly successful for Sartorius, both operationally and strategically," commented CEO Dr. Joachim Kreuzburg. "Our Bioprocess Solutions Division is continuing to expand strongly.
